Editas Medicine
IPO
- Headquarters
- Cambridge, Massachusetts
- Employees
- 201–500
- Founded
- 2013
- Business Model
- B2B
- Website
- editasmedicine.com
- Total Funding
- $163.0M
- Last Round
- $120.0M Series BAug 2015
About
Clinical-stage biotechnology company developing CRISPR-based genomic medicines for people with serious diseases.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account